Showing results (91-100 of 168) with videos related to

Sort By:
Pageof 17
Neoplasia (New York, N.Y.)|May 2, 2013
The role of sarcosine metabolism in prostate cancer progressionAmjad P Khan, Thekkelnaycke M Rajendiran, Bushra Ateeq, et al.
The Prostate|August 4, 2019
Characterization of glycine-N-acyltransferase like 1 (GLYATL1) in prostate cancerMarie-Lisa Eich, Darshan Shimoga Chandrashekar, Maria Del Carmen Rodriguez Pen A, et al.
Human Pathology|August 17, 2014
Prostate cancer with Paneth cell-like neuroendocrine differentiation has recognizable histomorphology and harbors AURKA gene amplificationKyung Park, Zhengming Chen, Theresa Y MacDonald, et al.
Photoacoustics|November 17, 2022
Assessment of prostate cancer progression using a translational needle photoacoustic sensing probe: Preliminary study with intact human prostates ex-vivoLinyu Ni, Wei-Kuan Lin, Amy Kasputis, et al.
Molecular Cancer Research : MCR|January 6, 2019
Multiclonality and Marked Branched Evolution of Low-Grade Endometrioid Endometrial CarcinomaLorena Lazo de la Vega, Mia C Samaha, Kevin Hu, et al.
Human Pathology|February 24, 2015
Cutaneous basal cell carcinosarcomas: evidence of clonality and recurrent chromosomal lossesPaul W Harms, Douglas R Fullen, Rajiv M Patel, et al.
Urologic Oncology|May 24, 2011
Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancerSimpa S Salami, Folke Schmidt, Bharathi Laxman, et al.
Human Pathology|April 13, 2016
Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutationsPaul W Harms, Daniel H Hovelson, Andi K Cani, et al.
Cancer Biomarkers : Section a of Disease Markers|March 20, 2025
A simplified MyProstateScore2.0 for high-grade prostate cancerTiffany M Tang, Yuping Zhang, Ana M Kenney, et al.
Human Pathology|October 29, 2017
The utility of SDHB and FH immunohistochemistry in patients evaluated for hereditary paraganglioma-pheochromocytoma syndromesAaron M Udager, Martin J Magers, Dayna M Goerke, et al.
Pageof 17